Literature DB >> 7558323

Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease.

C B Faulkner1, J W Simecka, M K Davidson, J K Davis, T R Schoeb, J R Lindsey, M P Everson.   

Abstract

Studies were conducted to determine whether the production of various cytokines is associated with Mycoplasma pulmonis disease expression. Susceptible C3H/HeN and resistant C57BL/6N mice were inoculated intranasally with 10(7) CFU of virulent M. pulmonis UAB CT or avirulent M. pulmonis UAB T. Expression of genes for tumor necrosis factor alpha (TNF-alpha), interleukin 1 alpha (IL-1 alpha), IL-1 beta, IL-6, and gamma interferon (IFN-gamma) in whole lung tissue and TNF-alpha gene expression in bronchoalveolar lavage (BAL) cells was determined by reverse transcription-PCR using specific cytokine primers at various times postinoculation. In addition, concentrations of TNF-alpha, IL-1, IL-6, and IFN-gamma were determined in BAL fluid and serum samples at various times postinoculation. Our results showed that there was a sequential appearance of cytokines in the lungs of infected mice: TNF-alpha, produced primarily by BAL cells, appeared first, followed by IL-1 and IL-6, which were followed by IFN-gamma. Susceptible C3H/HeN mice had higher and more persistent concentrations of TNF-alpha and IL-6 in BAL fluid than did resistant C57BL/6N mice, indicating that TNF-alpha and possibly IL-6 are important factors in pathogenesis of acute M. pulmonis disease in mice. Serum concentrations of IL-6 were elevated in C3H/HeN mice, but not C57BL/6N mice, following infection with M. pulmonis, suggesting that IL-6 has both local and systemic effects in M. pulmonis disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558323      PMCID: PMC173574          DOI: 10.1128/iai.63.10.4084-4090.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

Review 1.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

2.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 4.  Endotoxin and lung injury.

Authors:  K L Brigham; B Meyrick
Journal:  Am Rev Respir Dis       Date:  1986-05

5.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

6.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

7.  Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function.

Authors:  D K Blanchard; J Y Djeu; T W Klein; H Friedman; W E Stewart
Journal:  J Leukoc Biol       Date:  1988-05       Impact factor: 4.962

8.  Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice.

Authors:  R F Parker; J K Davis; D K Blalock; R B Thorp; J W Simecka; G H Cassell
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

Review 9.  Diagnosis of murine mycoplasmal infections by enzyme-linked immunosorbent assay (ELISA).

Authors:  J Davis; G H Cassell; G Gambill; N Cox; H Watson; M Davidson
Journal:  Isr J Med Sci       Date:  1987-06

10.  Differences in virulence for mice among strains of Mycoplasma pulmonis.

Authors:  M K Davidson; J R Lindsey; R F Parker; J G Tully; G H Cassell
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

View more
  37 in total

1.  Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite.

Authors:  J Hickman-Davis; J Gibbs-Erwin; J R Lindsey; S Matalon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Spiralin, a mycoplasmal membrane lipoprotein, induces T-cell-independent B-cell blastogenesis and secretion of proinflammatory cytokines.

Authors:  C Brenner; H Wróblewski; M Le Henaff; L Montagnier; A Blanchard
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 3.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Antimicrobial activity of inducible human beta defensin-2 against Mycoplasma pneumoniae.

Authors:  Koichi Kuwano; Noriko Tanaka; Takashi Shimizu; Yutaka Kida
Journal:  Curr Microbiol       Date:  2006-05-09       Impact factor: 2.188

5.  Surfactant dysfunction in SP-A-/- and iNOS-/- mice with mycoplasma infection.

Authors:  Judy M Hickman-Davis; Zhengdong Wang; German Alejandro Fierro-Perez; Patricia R Chess; Grier P Page; Sadis Matalon; Robert H Notter
Journal:  Am J Respir Cell Mol Biol       Date:  2006-08-17       Impact factor: 6.914

6.  Endothelial cell heterogeneity in venules of mouse airways induced by polarized inflammatory stimulus.

Authors:  T J Murphy; G Thurston; T Ezaki; D M McDonald
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

7.  Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma.

Authors:  Wees Love; Nicole Dobbs; Leslie Tabor; Jerry W Simecka
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

8.  Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.

Authors:  S C Cartner; J W Simecka; J R Lindsey; G H Cassell; J K Davis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 9.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.

Authors:  K Fukuchi; D Pham; M Hart; L Li; J R Lindsey
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.